ResearcherBaylor College of MedicineNo recent work listed
Wilson Luiz da Costa
Matched on ORCID iD 0000-0003-4460-4706; OpenAlex author ID A5070826741. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 3 papers · 2022: 1 paper
Papers 7
- Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreatic Adenocarcinoma. Co-author DOI 10.1097/sla.0000000000005249↗
- Disparities in access to health care system as determinant of survival for patients with pancreatic cancer in the State of São Paulo, Brazil. First author DOI 10.1038/s41598-021-85759-5↗
- Comparative Effectiveness of Neoadjuvant Therapy and Upfront Resection for Patients with Resectable Pancreatic Adenocarcinoma: An Instrumental Variable Analysi… Co-author DOI 10.1245/s10434-020-09327-3↗
- ASO Author Reflections: Multimodality Therapy for Patients with Pancreatic Cancer: Neoadjuvant Therapy for All? Co-author DOI 10.1245/s10434-020-09376-8↗
- Neoadjuvant Treatment for Patients With Localized Pancreatic Adenocarcinoma: Are We There Yet? Co-author DOI 10.1001/jamaoncol.2020.0562↗
- Trends in the Incidence of Pancreatic Adenocarcinoma in All 50 United States Examined Through an Age-Period-Cohort Analysis. Co-author DOI 10.1093/jncics/pkaa033↗
- Role of staging laparoscopy in the management of Pancreatic Duct Carcinoma (PDAC): Single-center experience from a tertiary hospital in Brazil. First author DOI 10.1002/jso.25024↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nader Nabile Massarweh · 4 shared papers, 2020–2022 · strength 0.85
- Paper ASO Author Reflections: Multimodality Therapy for Patients with Pancreatic Cancer: Neoadjuvant Therapy for All? DOI 10.1245/s10434-020-09376-8↗
- Paper Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreati… DOI 10.1097/sla.0000000000005249↗
- Paper Neoadjuvant Treatment for Patients With Localized Pancreatic Adenocarcinoma: Are We There Yet? DOI 10.1001/jamaoncol.2020.0562↗
- Hop S. Tran Cao · 3 shared papers, 2020–2022 · strength 0.57
- Paper Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreati… DOI 10.1097/sla.0000000000005249↗
- Paper Neoadjuvant Treatment for Patients With Localized Pancreatic Adenocarcinoma: Are We There Yet? DOI 10.1001/jamaoncol.2020.0562↗
- Paper Comparative Effectiveness of Neoadjuvant Therapy and Upfront Resection for Patients with Resectable Pancreatic Adenocar… DOI 10.1245/s10434-020-09327-3↗
- Felipe José Fernández Coimbra · 2 shared papers, 2018–2021 · strength 0.23
- Paper Disparities in access to health care system as determinant of survival for patients with pancreatic cancer in the State… DOI 10.1038/s41598-021-85759-5↗
- Paper Role of staging laparoscopy in the management of Pancreatic Duct Carcinoma (PDAC): Single-center experience from a tert… DOI 10.1002/jso.25024↗
- Victor Hugo Fonseca de Jesus · 2 shared papers, 2018–2021 · strength 0.23
- Paper Disparities in access to health care system as determinant of survival for patients with pancreatic cancer in the State… DOI 10.1038/s41598-021-85759-5↗
- Paper Role of staging laparoscopy in the management of Pancreatic Duct Carcinoma (PDAC): Single-center experience from a tert… DOI 10.1002/jso.25024↗
- Aaron P. Thrift · 1 shared paper, 2020 · strength 0.19
- Aldo Lourenço Abbade Dettino · 1 shared paper, 2021 · strength 0.15
- María Paula Curado · 1 shared paper, 2021 · strength 0.15
- Rachel P. Riechelmann · 1 shared paper, 2021 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.